Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antirheumatic Agents”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03264703
What this trial is testing

Study in Patients With Moderated to Severe Rheumatoid Arthritis Who Have Failed to Combination Therapy of Conventional Disease-modifying Antirheumatic Drugs (cDMARDs) to cDMARD Plus ANti-TNF Versus cDMARDs in Real World

Who this might be right for
Arthritis, Rheumatoid
Eisai Korea Inc. 212
Large-scale testing (Phase 3)Looking for participantsNCT03414502
What this trial is testing

Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response

Who this might be right for
Rheumatoid Arthritis
University of Nebraska 400
Large-scale testing (Phase 3)Study completedNCT02349295
What this trial is testing

Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Eli Lilly and Company 363
Not applicableStudy completedNCT05078502
What this trial is testing

Role of Vitamin D3 Supplementation With Conventional Synthetic Disease Modifying Antirheumatic Drugs(csDMARD) in Rheumatoid Arthritis Patients

Who this might be right for
Rheumatoid Arthritis
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 58
Large-scale testing (Phase 3)Active Not RecruitingNCT02629159
What this trial is testing

A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Adults With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate

Who this might be right for
Rheumatoid Arthritis
AbbVie 1,629
Testing effectiveness (Phase 2)Study completedNCT00292422
What this trial is testing

Dose-Escalating Study of BG9924 in Combination With Methotrexate in Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Biogen 50
Large-scale testing (Phase 3)Study completedNCT01711359
What this trial is testing

A Study in Participants With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Eli Lilly and Company 588
Not applicableLooking for participantsNCT05003310
What this trial is testing

ConsideRAte Study - Splenic Stimulation for RA

Who this might be right for
Rheumatoid Arthritis
Galvani Bioelectronics 28
Not applicableStudy completedNCT07436494
What this trial is testing

Coronavirus Anxiety in Patients Using Biologic vs Conventional DMARDs

Who this might be right for
COVID-19AnxietyRheumatic Diseases
Bursa City Hospital 200
Testing effectiveness (Phase 2)Study completedNCT07335952
What this trial is testing

Proximod, a Selective Sphingosine-1-phosphate Receptor 1 Modulator in Patients With Moderate-to-severe Active Rheumatoid Arthritis: a Double-blind, Randomised, Placebo-controlled, Phase 2 Trial.

Who this might be right for
Rheumatoid Arthritis
Peking University People's Hospital 179
Large-scale testing (Phase 3)Study completedNCT01830985
What this trial is testing

A Phase 2/3 Open-label Extension Study to Evaluate Long-Term Safety and Efficacy With VX-509 in Subjects With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Vertex Pharmaceuticals Incorporated 39
Large-scale testing (Phase 3)Ended earlyNCT04539873
What this trial is testing

Impact of Colchicine in Hospitalized Colombian Patients With COVID-19

Who this might be right for
Corona Virus Infection
Fundación Universitaria de Ciencias de la Salud 128
Not applicableUnknownNCT02401620
What this trial is testing

Validation of a Tolerability Questionnaire in Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Corporacion Parc Tauli 66
Not applicableStudy completedNCT01768858
What this trial is testing

Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn's Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical Practice

Who this might be right for
Rheumatoid ArthritisAnkylosing SpondylitisPsoriatic Arthritis+3 more
AbbVie 96
Post-approval studies (Phase 4)Study completedNCT02648464
What this trial is testing

Hydroxychloroquine for the Prevention of Cardiovascular Events in Myocardial Infarction Patients - a Safety Pilot Trial

Who this might be right for
Myocardial InfarctionAcute Coronary SyndromeInflammation+3 more
Helsinki University Central Hospital 125
Post-approval studies (Phase 4)UnknownNCT02634541
What this trial is testing

Adalimumab in Alleviating Inflammation in Patients With Axial Spondyloarthritis

Who this might be right for
Ankylosing Spondyloarthritis
University of Helsinki 60
Not applicableStudy completedNCT03327454
What this trial is testing

Benepali® PEN Patient Satisfaction Survey

Who this might be right for
Rheumatoid ArthritisSpondyloarthropathies
Biogen 500
Testing effectiveness (Phase 2)UnknownNCT02005757
What this trial is testing

Efficacy and Safety Study of Mizoribine in Active Rheumatoid (AMOLED)

Who this might be right for
Rheumatoid Arthritis
Chong Kun Dang Pharmaceutical 60
Not applicableStudy completedNCT01783730
What this trial is testing

Assessment of the Safety of Adalimumab in Rheumatoid Arthritis Patients Showing Rapid Progression of Structural Damage of the Joints, Who Have no Prior History of Treatment With Disease-modifying Anti-rheumatic Drugs or Biological Agents

Who this might be right for
Rheumatoid Arthritis
AbbVie 163
Testing effectiveness (Phase 2)Study completedNCT03349450
What this trial is testing

DPX-Survivac and Checkpoint Inhibitor in DLBCL

Who this might be right for
Adult Diffuse Large Cell LymphomaRecurrentAdult Refractory Diffuse Large B-Cell Lymphoma
Sunnybrook Health Sciences Centre 25
Next Page